Momentary shifts in mood, even those lasting just a matter of seconds, profoundly alter the brain’s response to pleasurable experiences in people with bipolar disorder, finds a new study by UCL researchers.
AusperBio’s AHB-137 breakthrough designation in China for CHB
AHB-137 is a new therapeutic option for patients with chronic hepatitis B. Credit: Peakstock/Shutterstock. AusperBio Therapeutics and Ausper Biopharma have gained breakthrough therapy designation (BTD)